Nippon India Mutual Fund increased its stake in Sanofi Consumer Healthcare India Limited from 4.85% to 5.21% by purchasing 84,584 shares, valued at ₹38.65 Cr at ₹4567.20 apiece. The fund crossed the 5% disclosure threshold.
A manufacturer and distributor of over-the-counter and consumer healthcare products in India, Sanofi Consumer Healthcare operates as a division of Sanofi, a global pharmaceutical company with decades of international experience. The company produces a diverse range of accessible health and wellness products designed for everyday consumer use across various therapeutic categories. Incorporated in 2023, it delivers trusted healthcare solutions to the Indian market by leveraging its parent company's established expertise and research capabilities.
India's fifth-largest AMC with over Rs 6 lakh crore in AUM, backed by Japan's Nippon Life Insurance which holds majority stake. Formerly Reliance MF, rebranded in 2019 after Nippon's acquisition. Sailesh Raj Bhan has run the equity book for over two decades and is one of India's most experienced active managers. Known for sector rotational calls and a deep research bench.